Evidence map›Paper›PMID 32284404›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

The T1D-associated lncRNA

Itziar Gonzalez-Moro, Ane Olazagoitia-Garmendia, Maikel L Colli, Nadia Cobo-Vuilleumier, Thomas S Postler, Lorella Marselli, Piero Marchetti, Sankar Ghosh, Benoit R Gauthier, Decio L Eizirik and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Computational and structural biotechnology journal · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Genomic Editing and Diabetes.Advances in experimental medicine and biology · 2023
    Article
  18. Article
  19. Insights from Dysregulated mRNA Expression Profile ofJournal of immunology research · 2022
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Itziar Gonzalez-MoroDepartment of Biochemistry and Molecular Biology, University of the Basque Country, 48940 Leioa, Spain.ORCID 0000-0002-6504-4931
Ane Olazagoitia-GarmendiaDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, 48940 Leioa, Spain.ORCID 0000-0002-2645-1518
Maikel L ColliULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, 1070 Brussels, Belgium.ORCID 0000-0002-2200-4761
Nadia Cobo-VuilleumierAndalusian Center for Molecular Biology and Regenerative Medicine-CABIMER (Centro Andaluz de Biología Molecular y Medicina Regenerativa), Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, 41092 Seville, Spain.ORCID 0000-0002-8164-3416
Thomas S PostlerDepartment of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York 10032.ORCID 0000-0002-3558-9084
Lorella MarselliDepartment of Clinical and Experimental Medicine, Cisanello University Hospital, 56126 Pisa, Italy.ORCID 0000-0002-6698-2962
Piero MarchettiDepartment of Clinical and Experimental Medicine, Cisanello University Hospital, 56126 Pisa, Italy.ORCID 0000-0003-4907-0635
Sankar GhoshDepartment of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York 10032.ORCID 0000-0002-3227-0588
Benoit R GauthierAndalusian Center for Molecular Biology and Regenerative Medicine-CABIMER (Centro Andaluz de Biología Molecular y Medicina Regenerativa), Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, 41092 Seville, Spain.ORCID 0000-0001-8146-7486
Decio L EizirikULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, 1070 Brussels, Belgium.ORCID 0000-0003-2453-5889
Ainara Castellanos-RubioDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, 48940 Leioa, Spain; ainara.castellanos@ehu.eus izortze.santin@ehu.eus.ORCID 0000-0003-3192-9544
Izortze SantinDepartment of Biochemistry and Molecular Biology, University of the Basque Country, 48940 Leioa, Spain; ainara.castellanos@ehu.eus izortze.santin@ehu.eus.ORCID 0000-0003-1651-6776
University of the Basque Country · ESColumbia University · USOspedale Cisanello · ITUniversité Libre de Bruxelles · BECentro Andaluz de Biología Molecular y Medicina Regenerativa · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vast majority of type 1 diabetes (T1D) genetic association signals lie in noncoding regions of the human genome. Many have been predicted to affect the expression and secondary structure of long noncoding RNAs (lncRNAs), but the contribution of these lncRNAs to the pathogenesis of T1D remains to be clarified. Here, we performed a complete functional characterization of a lncRNA that harbors a single nucleotide polymorphism (SNP) associated with T1D, namely,

Indexed as

3' Untranslated RegionsCell SurvivalDiabetes Mellitus, Type 1Genetic Predisposition to DiseaseHEK293 CellsHumansInsulin-Secreting CellsJurkat CellsPoly I-CPolymorphism, Single NucleotidePrimary Cell CultureRNA-Binding ProteinsRNA, Long NoncodingRNA, MessengerRNA StabilityRNA, Viral3' Untranslated RegionsPCBP2 protein, humanPoly I-CRNA-Binding ProteinsRNA, Long NoncodingRNA, MessengerRNA, ViralSTAT1 protein, humanSTAT1 Transcription FactorinflammationlncRNApancreatic β-cellpolymorphismtype 1 diabetes

Identifiers

PMID32284404
PMCPMC7183221
OpenAlexW3015628544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.